Second shot at hope: early booster dose tested to keep leukemia at bay
NCT ID NCT05460533
First seen Nov 01, 2025 · Last updated Apr 21, 2026 · Updated 25 times
Summary
This study is testing whether giving a second dose of CAR-T cell therapy early can help keep leukemia in remission longer for children and young adults who have already received this treatment. Researchers want to see if this early 'booster' dose can prevent the cancer from coming back by keeping immune cells that fight leukemia active. The study will enroll 30 participants who have already received CAR-T therapy and have an additional dose available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Colorado (Data Collection Only)
Aurora, Colorado, 80045, United States
-
Children's Hospital of Los Angeles (Data Collection Only)
Los Angeles, California, 90027, United States
-
Cincinnati Children's Hospital Medical Center (Data Collection Only)
Cincinnati, Ohio, 45229, United States
-
Johns Hopkins University (Data Collection Only)
Baltimore, Maryland, 21287, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Stanford University (Data Collection Only)
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.